Tags |
|
|
Links |
|
|
Advice You - The Rules and Ambiguity of Most-Management
There is a class of management….equivalent, say, to 2nd and 1st lieutenants. They have no real mana
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
gement authority. They often cannot even recommend. They are almost always promoted from the ranks.
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
If not, that is their genealogy. They receive no management training… Or, if they do, it has litt
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
e or nothing to do with their jobs. I say this is so for most managers…and so I call this class of
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
management ‘most-management’.
There is an underlying fabric of agreements (for example, I work a fu
There is an underlying fabric of agreements (for example, I work a fu
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
l week; you pay me money..) These can be generic (as receiving pay) or may be personal…[Say, boss..
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
I’m going to work late tonight and tomorrow and take Friday afternoon off…Okay with you? (This is a
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
so a request)].
There are an extraordinary number of unclear agreements between them and both their
There are an extraordinary number of unclear agreements between them and both their
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
bosses and their people… Agreements that only one of you think exist. For example: what constitute
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
a good job: what qualifies for promotions or level of raises…When you can refuse to work late or re
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
fuse a request.. Who you’re allowed to communicate with and how…. What to wear…
Most-managers want
Most-managers want
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
to know what works as a manager too. When they don’t know something they are afraid to ask their b
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ss and embarrassed to ask their peers. But they don’t know what they’re allowed to do or not do. T
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
hey are powerless managers, ignorant of the scope of their authority – even if they have some.
Nobo
Nobo
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
y ever told them what they were allowed to do and not do. The aggressive ones find out by overstepp
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ing their bounds and getting their wrists slapped (‘..easier to get forgiveness than permission’).
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
he others stay hunkered down.
They do know that they have a lot of responsibility and accountabilit
They do know that they have a lot of responsibility and accountabilit
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
y – for the first time. Even having had the job for a while is no indication that they’ve learned a
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ything about being a manager. But the people reporting to them treat them as managers. Since they
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
had frequently been peers, this adds an additional awkwardness to their job.
So – how do they learn
So – how do they learn
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/20423/adviceyou-The-Rules-and-Ambiguity-of-MostManagement.html">The Rules and Ambiguity of Most-Management</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/20423/adviceyou-The-Rules-and-Ambiguity-of-MostManagement.html]The Rules and Ambiguity of Most-Management[/url]
Related Articles:
Club Flyers for your Big Event
Brand Naming - Art, Skill, and Luck!
Black Men Without a College Degree are Less Employable
Bookmark it:
|